Year: 2019
Type: article
Abstract: The t(8;21) is one of the most frequent chromosomal translocations associated with acute myeloid leukemia (AML). We found that t(8;21) AML were extremely sensitive to THZ1, which triggered apoptosis after only 4 h. We used precision nuclear run-on transcription sequencing (PROseq) to define the global effects of THZ1 and other CDK inhibitors on RNA polymerase II dynamics. Inhibition of CDK7 using THZ1 caused wide-spread loss of promoter-proximal paused RNA polymerase. This loss of 5' pausing was associated with accumulation of polymerases in the body of a large number of genes. However, there were modest effects on genes regulated by 'super-enhancers'. At the 3' ends of genes, treatment with THZ1 suppressed RNA polymerase 'read through' at the end of the last exon, which resembled a phenotype associated with a mutant RNA polymerase with slower elongation rates. Consistent with this hypothesis, polyA site-sequencing (PolyA-seq) did not detect differences in poly A sites after THZ1 treatment. PROseq analysis after short treatments with THZ1 suggested that these 3' effects were due to altered CDK7 activity at the 5' end of long genes, and were likely to be due to slower rates of elongation.
Source: Nucleic Acids Research
DOI: 10.1093/nar/gkz127
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,992
Funders: American Cancer Society, T.J. Martell Foundation, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources
Awards: G1300984159, G1554689623, G1743490862, Functions of Histone Ubiquitination and Methylation, G4017495986, G565149442, Role of AML1-ETO in Acute Leukemia, Establishing that Hdac3 is a therapeutic target in a subset of B cell Lymphoma, Illumina Genome Analyzer II, G823921766, Regulation of transcription and tumor suppression by MTG family members, Molecular and Cellular Basis for Digestive Diseases, Biochemical and Chemical Training for Cancer Research, Cancer Center Support Grant
OpenAlex ID: W2915088120
